(Date:11/8/2009)...ON, Nov. 7 Today, the H...Kaptur, Dahlkemper, Smith, Ellsworth and Lipinski ...ca Act" (H.R. 3962). The amendment maintains the c...ortion and for benefits packages that include abor...o receive affordability credits and those who do n...
(Date:11/8/2009)...or Swift Passage of H.R. 3961 to Secure the Stabil...-USNewswire/ -- Statement Attributable to: J. Jame...ation. ,, (Logo: http://www.newscom.com/cgi-b...the passage of the House health reform bill, which...and physicians and calls for swift passage of H.R....
(Date:11/8/2009)...D, Calif., Nov. 8 March...Babies luncheon to recognize prominent individuals...nd who are role models for March of Dimes commitme...e March of Dimes November Prematurity Awareness Mo...urged to join the fight for preemies! ,, (Photo...
(Date:11/7/2009)...yn T. Coleman (CT), David A. Cook (GA), Louis J. G... (LA) Honored ,, CHICAGO, Nov. 7 /PRNewswire-U...A) today presented five medical society executive ...tributions to the goals and ideals of the medical ... semi-annual policy making meeting in Houston. ,...
(Date:11/7/2009)...ON, Nov. 7 The U.S. bis...esentatives to vote for the Stupak-Ellsworth Amend...Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith A... abortion funding and conscience protections in th...2)," they said. ,, The letter was signed by Car...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2...an scientist of Indian origin has been declared th...w system which makes use of data for improving cli...the Senior Director of Engineering Research Develo...able Extraction and Meaningful Inference from Nons...
...o in for wholesome and healthy food, beer drinkers...lity rates are also seen among// wine drinkers wh...he National Institute of Public Research in Copenh...Studying 3.5 million supermarket transactions, the...
...n and colleagues from Cochrane Collaboration (Inte...w from compiling data from various clinical trials...ving influenza symptoms and treatment. //
The... which were used to control symptoms and kill infl...
...in Scotland are being encouraged to employ people ...ties while relating and communicating with others....from this disorder, which is a barrier to them get...lligence of those who suffer from this condition c...
...er University has reported in the Journal Science ...that the scientists screened 480 strains of Strept... that all the strains were multi-drug resistance /... bacteria were collected from different soil sampl...
...transmission case is due today in Harbin court tod... 15 people through blood collected from an infecte...uction farm hospital in Heilongjiang province of N... infection indirectly from the infected, as they w...
Other Medicine News:(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...e/ -- NexBio Inc., in collaboration with scientist...n (CDC), St. Louis University, and the University ...wo articles in the peer-reviewed journal PLoS ONE....(Fludase ® ) may play a potentially important...emic Influenza A(H1N1) and drug-resistant influenz...
(Date:11/5/2009)...ewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OS...roducts for regenerative healing, today reported f...mber 30, 2009. ,, "During the third quarter of ...w biologic products MagniFuse(TM) Bone Graft, Fac...novative Grafting," said Sam Owusu-Akyaw, Presiden...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8PRA International to Host Audio Conference 55394 1PRA International to Host Audio Conference 55394 2Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 55389 1Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 55389 2Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 1Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 2Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 3Nuvilex Launches Last Shot Hangover Remedy 28TM 29 Web Site 55385 4...atch, a publishing and,information services compan..., finds that investigative sites are required to l...s. More than 75% of respondents to a recent,Center...on three or more,EDC systems. In addition, a major...training had improved., State of the Clinical Tri...
...d soon after CEA Trial data reports in third quart...ISCO, May 15 VIA Pharmaceuticals,Inc. (Nasdaq: V...lopment of,compounds for the treatment of cardiova...ted patient enrollment in its acute coronary syndr...se 2 trials investigating VIA-2291,the company,s l...
Other Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Ident-A-Drug Reference 2005
...fic clinical trial activity and drug development u...rom CenterWatch. This highly valuable resource has... of medical breakthroughs on the frontiers of medi...ults, Newly Approved Drugs, Clinical Trials Listin...
Thomson CenterWatch Clinical Trial Listings
Drug Facts - Gold (A to Z Drugs and Drug Interaction)
Medicine Products: